针对瘤的PROTAC原药纳米平台可实现精确的蛋白质降解和组合癌症治疗

Zhi-Feng Zou1,2, Lei Yang2,3, Hui-Jun Nie3

  • 1School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.

PubMed
概括

这项研究引入了一种聚合物结合的PROTAC预制药平台,用于向癌症治疗. 这种创新的纳米粒子系统增强了药物输送,提高了瘤的特异性,并为复杂疾病提供了组合治疗的好处.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K